HIPPO (sudeng) fluctuated 41.5% in 24 hours: Binance Futures delisting announcement triggered selling pressure followed by a short squeeze rebound
Bitget Pulse2026/05/14 03:59Volatility Brief
In the past 24 hours, HIPPO price rebounded from a low of $0.000234 to a high of $0.000331, currently trading at $0.000263, with a fluctuation amplitude of 41.5%. Trading volume significantly expanded, reaching $2.49 million to $9.6 million, a week-on-week growth of 97%-142%.
Analysis of the Cause of the Move
- Binance Futures delisting announcement directly triggered initial selling pressure, pushing the price to the 24-hour low.
- Subsequently, a surge in trading volume sparked a short squeeze rebound, with the price quickly rising to the high point.
Market Views and Outlook
The community and traders view HIPPO as a short-term leading coin. Discussions on X focus on its “consolidation build-up” and “breakout” potential, but also warn of a “potential pullback after euphoric rally.” Market volatility is expected to remain high; attention should be paid to trading volume and on-chain activities, as short-term rebound momentum may weaken.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.
Crypto prices
More
